VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
MED
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
MEDMedifast, Inc.
$11.95$133M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksMEDQuarterly Financials

Medifast, Inc. (MED) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Medifast, Inc. (MED) quarterly income statement — complete revenue, gross profit & net income history

Income StatementBalance SheetCash FlowRatios

MED Income Statement

Quarterly statement

MED Income Statement

Medifast, Inc. (MED) annual income statement — 30-year revenue, gross profit & net income history

AnnualQuarterly
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21
Sales/Revenue76.38M76.04M75.1M89.41M105.56M115.73M119M140.16M168.56M174.74M191.01M235.87M296.19M348.98M337.25M390.4M453.33M417.6M377.83M413.39M
Revenue Growth %-27.64%-34.29%-36.9%-36.21%-37.38%-33.77%-37.7%-40.58%-43.09%-49.93%-43.36%-39.58%-34.66%-16.43%-10.74%-5.56%15%22.58%42.63%52.28%
Cost of Goods Sold22.99M24.29M22.96M27.25M28.91M31.48M30.78M34.49M45.12M47.45M49.65M58.49M85.47M102.59M103.65M107.55M131.65M115.31M99.55M106.34M
COGS % of Revenue30.1%31.94%30.57%30.48%27.39%27.2%25.87%24.61%26.77%27.15%25.99%24.8%28.86%29.4%30.73%27.55%29.04%27.61%26.35%25.72%
Gross Profit53.4M51.76M52.14M62.16M76.64M84.25M88.22M105.67M123.44M127.29M141.37M177.38M210.72M246.39M233.6M282.85M321.68M302.29M278.29M307.06M
Gross Margin %69.9%68.06%69.43%69.52%72.61%72.8%74.13%75.39%73.23%72.85%74.01%75.2%71.14%70.6%69.27%72.45%70.96%72.39%73.65%74.28%
Gross Profit Growth %-30.33%-38.56%-40.9%-41.18%-37.91%-33.82%-37.6%-40.42%-41.42%-48.34%-39.48%-37.29%-34.5%-18.49%-16.06%-7.88%9.52%21.62%39.67%50.49%
Operating Expenses57.72M52.85M59.94M66.24M77.71M85.51M87.51M103.57M131.31M119.35M132.69M151.87M172.01M192.88M201M234.69M272.72M247.2M231.45M251.89M
OpEx % of Revenue75.57%69.5%79.82%74.09%73.62%73.89%73.54%73.89%77.9%68.3%69.47%64.39%58.07%55.27%59.6%60.12%60.16%59.2%61.26%60.93%
Selling, General & Admin57.72M55.05M59.94M66.24M77.71M85.51M87.51M103.57M131.31M119.35M132.69M151.87M172.01M192.88M201M234.69M272.72M247.2M231.45M251.89M
SG&A % of Revenue75.57%72.39%79.82%74.09%73.62%73.89%73.54%73.89%77.9%68.3%69.47%64.39%58.07%55.27%59.6%60.12%60.16%59.2%61.26%60.93%
Research & Development01.1M000000000000000000
R&D % of Revenue-1.45%------------------
Other Operating Expenses0-1000K000000000000000000
Operating Income-4.33M-1.09M-7.8M-4.08M-1.07M-1.26M709K2.11M-7.88M7.94M8.68M25.51M38.71M53.51M32.6M48.16M48.96M55.09M46.84M55.17M
Operating Margin %-5.66%-1.44%-10.39%-4.56%-1.01%-1.09%0.6%1.5%-4.67%4.54%4.54%10.81%13.07%15.33%9.67%12.34%10.8%13.19%12.4%13.35%
Operating Income Growth %-305.91%13.23%-1200.56%-293.78%86.47%-115.89%-91.83%-91.74%-120.35%-85.16%-73.39%-47.03%-20.95%-2.86%-30.4%-12.72%-20.3%4.33%23.36%23.82%
EBITDA-2.99M2.39M-4.34M-629K2.98M2.02M3.89M5.3M-4.81M11.2M12.03M28.92M42.07M56.48M35.55M51.01M51.7M57.53M51.44M56.48M
EBITDA Margin %-3.92%3.14%-5.78%-0.7%2.82%1.74%3.27%3.78%-2.85%6.41%6.3%12.26%14.21%16.19%10.54%13.07%11.4%13.78%13.62%13.66%
EBITDA Growth %-200.4%18.34%-211.4%-111.87%161.95%-81.98%-67.63%-81.67%-111.43%-80.17%-66.17%-43.3%-18.61%-1.82%-30.89%-9.7%-17.63%6.69%28.68%21.9%
D&A (Non-Cash Add-back)03.48M3.46M3.45M4.04M3.28M3.19M3.19M3.07M3.26M3.35M3.41M3.37M2.97M2.95M2.85M2.73M2.44M4.61M1.31M
EBIT-2.99M-1.94M-6.38M-2.66M2.88M526K1.27M1.58M-10.65M11.59M8.68M25.51M38.71M53.51M32.64M48.16M48.96M55.07M46.84M55.29M
Net Interest Income1.35M1.38M1.42M1.43M1.37M1.3M953K1.33M1.3M1.22M1.18M1.03M462K-181K-182K-261K-164K-95K-93K-94K
Interest Income1.35M1.38M1.42M1.43M1.37M1.3M953K1.33M1.3M1.22M1.18M1.03M462K0000000
Interest Expense0000000000000181K182K261K164K95K93K94K
Other Income/Expense1.34M-846K1.42M1.42M3.94M1.79M566K-528K-2.77M3.65M1.13M1.04M411K-182K-191K-278K-168K-111K-86K21K
Pretax Income-2.99M-1.94M-6.38M-2.66M2.88M526K1.27M1.58M-10.65M11.59M9.8M26.55M39.12M53.33M32.41M47.88M48.8M54.98M46.75M55.19M
Pretax Margin %-3.92%-2.55%-8.5%-2.97%2.72%0.45%1.07%1.13%-6.32%6.63%5.13%11.26%13.21%15.28%9.61%12.26%10.76%13.16%12.37%13.35%
Income Tax109K181K11.74M-396K395K1.3M474K449K-2.5M3.27M3.77M3.42M8.84M13.36M5.89M11.72M9.68M13.2M12.73M13.21M
Effective Tax Rate %-3.64%-9.33%-183.91%14.9%13.74%246.77%37.18%28.45%23.44%28.22%38.43%12.87%22.59%25.05%18.17%24.49%19.84%24%27.23%23.93%
Net Income-3.1M-2.12M-18.12M-2.26M2.48M-772K801K1.13M-8.15M8.32M6.04M23.13M30.28M39.97M26.52M36.16M39.11M41.78M34.02M41.98M
Net Margin %-4.06%-2.79%-24.13%-2.53%2.35%-0.67%0.67%0.81%-4.84%4.76%3.16%9.81%10.22%11.45%7.86%9.26%8.63%10.01%9%10.16%
Net Income Growth %-225%-174.87%-2362.05%-300.27%130.41%-109.28%-86.73%-95.12%-126.93%-79.19%-77.24%-36.02%-22.58%-4.34%-22.06%-13.88%-16.72%1.75%21.54%21.85%
Net Income (Continuing)-3.1M-2.12M-18.12M-2.26M2.48M-772K801K1.13M-8.15M8.32M6.04M23.13M30.28M39.97M26.52M36.16M39.11M41.78M34.02M41.98M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.28-0.19-1.65-0.210.22-0.070.070.10-0.750.760.502.122.773.672.393.273.423.592.893.56
EPS Growth %-227.27%-171.43%-2457.14%-310%129.33%-109.21%-86%-95.28%-127.08%-79.29%-79.08%-35.17%-19.01%2.23%-17.3%-8.15%-13.64%3.76%22.46%22.34%
EPS (Basic)-0.28-0.19-1.65-0.210.23-0.070.070.10-0.750.760.502.122.783.682.403.303.443.622.913.59
Diluted Shares Outstanding11.13M11.01M10.99M10.99M11.06M10.95M10.98M10.97M10.94M10.96M10.94M10.93M10.92M10.9M11.09M11.04M11.44M11.64M11.79M11.79M
Basic Shares Outstanding11.13M11.01M10.99M10.99M10.99M10.95M10.94M10.94M10.94M10.91M10.89M10.89M10.89M10.86M11.03M10.96M11.35M11.56M11.69M11.69M
Dividend Payout Ratio----0.04%--0.09%-8.54%297.9%78%58.89%47.95%67.58%50.01%48.47%39.87%50%39.9%